Venlafaxine ER 75mg Capsules from Canada
Extended-release venlafaxine hydrochloride capsules, 75mg, for major depressive disorder and generalized anxiety by modulating serotonin and norepinephrine in the CNS. Fits HTS 3004.90.92.49 for other CNS-affecting medicaments in retail-ready measured doses. Not covered by exclusions like foods or diagnostic reagents.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit drug master files (DMF) for extended-release formulations to prove bioequivalence
• Avoid misclassification by documenting CNS primary action; pitfall is bulk import without retail packing
• Ensure child-resistant packaging compliance for retail sale forms